The FDA just changed the game for peptides. April 2026 The FDA is reviewing Category 2 peptides for potential removal from restricted status. Full approval for some peptides may be Two new treatments, now available Copper Peptide Skin Complex brings prescription grade GHK Cu Acetate to support skin repair and renewal at the cellular level. Lash Growth Serum combines bimatoprost and latanoprost, prescription strength January 2026 FDA New Drug Approvals Zycubo (copper histidinate) Some approvals mark progress. Others redefine what hope looks like. In January 2026, the U.S. FDA approved Zycubo (copper histidinate injection formerly Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma